FDA Inspection
LEESAR, INCLEESAR, INC – FDA Inspection, May 9, 2025
Record Details
This FDA Inspection record concerns LEESAR, INC, with an inspection on May 9, 2025, issued by the Florida District Office, covering human drugs.
View Company Profile
ID · 5b5e6da8-89f6-4626-8c6e-8ccebe6bbb3d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1269588
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.180(e)Records reviewed annually
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of LEESAR, INC
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 23, 2026 | Not classified | Florida District Office | |
| July 18, 2025 | NAI | Florida District Office | Postmarket Assurance: Medical Devices |
| October 29, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 12, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 8, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for LEESAR, INC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.